Literature DB >> 7923193

Purified human MSH2 protein binds to DNA containing mismatched nucleotides.

R Fishel1, A Ewel, M K Lescoe.   

Abstract

The human hMSH2 protein is a member of a highly conserved family of postreplication mismatch repair components found from bacteria to humans. Alterations of the gene coding for this protein cosegregate with, and are the likely cause of, chromosome 2-linked hereditary nonpolyposis colon cancer. Postreplication mismatch repair has been found to faithfully replace misincorporated nucleotides, thereby increasing the overall fidelity of DNA replication. Loss of postreplication mismatch repair function leads to a mutator phenotype, which is proposed to account for the multiple mutations required for multistep carcinogenesis. Although the functions of hMSH2 can be anticipated based on its similarity to well-characterized bacterial and yeast proteins, proof of its functions has not been established. Here we demonstrate that purified hMSH2 binds specifically to mismatched nucleotides, providing a target for the excision repair processes characteristic of postreplication mismatch repair.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923193

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases.

Authors:  Deepa Subramanian; Jack D Griffith
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

2.  Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.

Authors:  A Brieger; J Trojan; J Raedle; G Plotz; S Zeuzem
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 3.  Progress against cancer.

Authors:  S Broder; J E Karp
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

4.  Recognition of DNA alterations by the mismatch repair system.

Authors:  G Marra; P Schär
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

5.  Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  J M Carethers; M T Hawn; D P Chauhan; M C Luce; G Marra; M Koi; C R Boland
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

6.  hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6.

Authors:  S Acharya; T Wilson; S Gradia; M F Kane; S Guerrette; G T Marsischky; R Kolodner; R Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Functional overlap in mismatch repair by human MSH3 and MSH6.

Authors:  A Umar; J I Risinger; W E Glaab; K R Tindall; J C Barrett; T A Kunkel
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

8.  hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha.

Authors:  I Iaccarino; G Marra; F Palombo; J Jiricny
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

Review 9.  Replication errors: cha(lle)nging the genome.

Authors:  J Jiricny
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

10.  Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth.

Authors:  Yan-Xia Zhang; Zhen Yue; Ping-Yu Wang; You-Jie Li; Jia-Xuan Xin; Min Pang; Qing-Yin Zheng; Shu-Yang Xie
Journal:  Biomed Pharmacother       Date:  2012-12-28       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.